Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2–, PIK3CA-mutated breast cancers

Overview of attention for article published in Genome Medicine, April 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Readers on

mendeley: 12 Mendeley

So far, Altmetric has seen 1 patent that references this research output.

METHODS AND SYSTEMS FOR DETERMINING CLONALITY OF SOMATIC SHORT VARIANTS

Application WO-2024124195-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity.